What Do Peptides Do in the Body? Hormones, Neurotransmission & Immune Defense

Peptide hormones constitute the largest class of signaling molecules in human endocrinology. Insulin, a 51-amino-acid peptide produced by pancreatic beta cells, regulates glucose homeostasis through the PI3K/AKT signaling pathway, mediating glucose transporter (GLUT4) translocation and glycogen synthesis. Oxytocin, a 9-amino-acid cyclic peptide synthesized in the hypothalamus, modulates social bonding, uterine contraction, and lactation through G-protein-coupled receptor signaling. Vasopressin (antidiuretic hormone), structurally similar to oxytocin, regulates water reabsorption in the renal collecting ducts via V2 receptors.

The peptide therapeutics market has grown substantially, reaching approximately $46 billion globally in 2024, with approximately 120 peptide drugs currently approved for clinical use across various therapeutic areas. In 2024 alone, the FDA approved 3 new peptide-based drugs, reflecting continued pharmaceutical industry investment in peptide modalities. These approved peptide drugs span indications from metabolic disease (GLP-1 receptor agonists) to oncology (somatostatin analogs) to rare genetic disorders.

Neuropeptides are a diverse class of signaling molecules that modulate synaptic transmission, pain perception, mood, and autonomic function throughout the central and peripheral nervous systems. Unlike classical neurotransmitters (acetylcholine, dopamine, serotonin), neuropeptides are stored in large dense-core vesicles, released upon sustained neuronal firing, and act through G-protein-coupled receptors with slower onset but longer-lasting modulatory effects.

Beta-endorphin, a 31-amino-acid peptide derived from proopiomelanocortin (POMC), is the principal endogenous ligand for mu-opioid receptors and mediates analgesic, euphoric, and stress-response effects. Substance P, an 11-amino-acid peptide of the tachykinin family, acts through the NK1 (neurokinin-1) receptor to mediate pain signaling, neurogenic inflammation, and emesis. Calcitonin gene-related peptide (CGRP), a 37-amino-acid neuropeptide, is a potent vasodilator implicated in migraine pathophysiology, which has led to the development of anti-CGRP monoclonal antibodies and CGRP receptor antagonists as therapeutics.

• Beta-endorphin: mu-opioid receptor agonist — pain modulation and stress response
• Substance P: NK1 receptor — pain transmission and neurogenic inflammation
• CGRP: calcitonin receptor-like receptor — vasodilation and migraine pathophysiology
• Neuropeptide Y: Y1-Y5 receptors — appetite regulation and anxiolysis
• Cholecystokinin: CCK-A/B receptors — satiety signaling and gallbladder contraction
• Somatostatin: SST1-5 receptors — inhibition of growth hormone and insulin secretion

The innate immune system deploys a sophisticated arsenal of antimicrobial peptides (AMPs) as a first line of chemical defense against microbial pathogens. Human defensins, comprising both alpha-defensins (predominantly expressed in neutrophils and Paneth cells) and beta-defensins (expressed in epithelial tissues), disrupt microbial membranes through electrostatic interactions with negatively charged lipid bilayer components. Beyond direct microbicidal activity, defensins function as chemoattractants for T cells, dendritic cells, and monocytes, bridging innate and adaptive immunity.

The human cathelicidin LL-37 (derived from the 18 kDa precursor hCAP-18) is a 37-residue alpha-helical peptide with broad-spectrum antimicrobial activity against bacteria, fungi, and enveloped viruses. LL-37 is expressed in neutrophils, monocytes, and epithelial cells, and its expression is upregulated by vitamin D receptor signaling. As reviewed by Bowdish et al. (2006), LL-37 also modulates inflammatory signaling by binding and neutralizing lipopolysaccharide (LPS) and by influencing toll-like receptor (TLR) signaling pathways.

Peptide growth factors orchestrate tissue repair, regeneration, and remodeling through autocrine, paracrine, and endocrine signaling. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex), an endogenous tripeptide identified in human plasma at concentrations that decline with age, has been shown to influence the expression of over 4,000 genes in human fibroblast genome-wide expression studies. These regulated genes include those involved in collagen synthesis, antioxidant defense, anti-inflammatory signaling, and stem cell recruitment.

Epidermal growth factor (EGF), transforming growth factor-beta (TGF-beta), and platelet-derived growth factor (PDGF) are peptide growth factors critical to wound healing cascades. They coordinate the sequential phases of hemostasis, inflammation, proliferation, and remodeling through receptor tyrosine kinase and serine/threonine kinase signaling pathways. Dysregulation of these peptide signaling networks is implicated in pathological conditions including chronic wounds, fibrosis, and oncogenesis.

Peptides play essential roles in the regulation of enzymatic activity throughout human physiology. Angiotensin II, an 8-amino-acid peptide generated by the renin-angiotensin-aldosterone system (RAAS), is a potent vasoconstrictor that acts through AT1 receptors on vascular smooth muscle cells. This peptide also stimulates aldosterone secretion from the adrenal cortex, promoting sodium and water retention. The clinical significance of this peptide cascade is evidenced by the widespread use of ACE inhibitors and angiotensin receptor blockers in cardiovascular medicine.

Endogenous peptide inhibitors also regulate protease activity in tissue homeostasis and disease. Tissue inhibitors of metalloproteinases (TIMPs), while larger than classical peptides, exemplify the principle of peptide-mediated enzyme regulation. At the smaller scale, endogenous opioid peptides (enkephalins, endorphins, dynorphins) regulate neurotransmitter release through presynaptic opioid receptor activation, effectively modulating the enzymatic and signaling machinery of synaptic transmission.

The breadth of peptide functions in human physiology — from hormone signaling and neurotransmission to immune defense and enzyme regulation — underscores why peptides have become one of the most active areas of pharmaceutical research. As noted by Al Musaimi et al. (2025), the peptide drug pipeline continues to expand, driven by advances in peptide synthesis, formulation, and delivery technologies that address historical limitations of peptide therapeutics including short half-life and limited oral bioavailability.

Endogenous peptides are classified by function: peptide hormones (insulin, glucagon, GLP-1, oxytocin) regulate metabolism and physiology; neuropeptides (endorphins, enkephalins, substance P) modulate neural signaling; antimicrobial peptides (defensins, cathelicidins, dermcidins) provide innate immune defense; and cytokine peptides coordinate inflammatory and immune responses.

Peptide hormones are hydrophilic, cannot cross cell membranes passively, and bind to cell-surface receptors (typically GPCRs or receptor tyrosine kinases) to initiate intracellular signaling cascades. Steroid hormones are lipophilic, diffuse through membranes, and bind intracellular nuclear receptors to directly modulate gene transcription. These fundamental differences dictate their distinct signaling kinetics and research methodologies.

Researchers use radioimmunoassays (RIA) and ELISA to quantify circulating peptide levels, mass spectrometry-based peptidomics for comprehensive identification, receptor binding assays with radiolabeled or fluorescent peptide analogs, and knockout/knockin animal models to study loss or gain of function. Patch-clamp electrophysiology measures neuropeptide effects on ion channel activity in neuronal preparations.

Explore detailed chemical profiles and research guides for compounds discussed in this article:

• GHK-Cu: Complete Research Guide → /learn/ghk-cu
• LL-37: Complete Research Guide → /learn/ll-37-research-guide-chemical-profile
• Oxytocin: Complete Research Guide → /learn/oxytocin

• Read more: RFK Jr. Signals Reversal of Peptide Ban: 14 of 19 Restricted Compounds May Return → https://www.chemverify.com/learn/rfk-jr-signals-reversal-of-peptide-ban-14-of-19-restricted-compounds-may-return
• Read more: AI-Guided High-Throughput Screening Accelerates Antimicrobial Peptide-Mimicking Polymer Discovery → https://www.chemverify.com/learn/ai-guided-antimicrobial-peptide-polymer-discovery
• Read more: Re-Engineering Insulin for Oral Delivery: Structural Modifications and Formulation Advances → https://www.chemverify.com/learn/insulin-oral-delivery-peptide-engineering
• Read more: Cyclic Lipopeptides: Biosurfactant Peptides as Next-Generation Drug Delivery Modulators → https://www.chemverify.com/learn/cyclic-lipopeptides-drug-delivery-modulators
• Read more: Microneedle-Delivered Peptide Decoy Receptors Show Promise in Psoriasis Treatment → https://www.chemverify.com/learn/microneedle-peptide-decoy-receptors-psoriasis